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ABSTRACT
Objective: Stroke (cerebrovascular accident) generally occurs more often in children than once 
suspected, with its attendant potential consequences. It is an under recognized cause of neurologic 
disabilty in children, with varied causes. Stroke is a devastating and potentially life threatening 
complication of sickle cell anaemia (SCA). Children with sickle cell haemoglobinopathy have a life time 
increased risk of developing a stroke. This study aims to assess the pattern of stroke presentation among 
SCA children in Sokoto, North-Western Nigeria. 
Methodology: A review of all the clinical records of children with SCA who were diagnosed and managed 
for sickle cell related stroke at Usmanu Danfodiyo University Teaching Hospital (UDUTH) Sokoto; 
Nigeria, over a ten-year period (May, 2004 – April, 2014) was undertaken. Data analysis was done using 
the statistical package for social sciences (SPSS) version 20.  
Results: Fifteen cases of Paediatrics stroke were identified, out of a total of 416 registered children with 
SCA, giving a stroke prevalence of 3.6%. Male: Female ratio was 1:1. All the stroke cases were of 
haemoglobin SS electrophoresis; with a mean age at diagnosis of SCA of 2.2 (±1.5) years and mean age at 
stroke onset of 6.3 (±2.8) years. Mean time of hospital presentation after the stroke onset was 10 (±2.5) 
days. Hemiparesis and expressive aphasia were the predominant presenting features. Based on the 
neuroimaging findings, majority of the stroke types were infarctive (71.4%). No mortality was recorded.
Conclusion: The prevalence of sickle cell related childhood stroke of 3.6% in this series is relatively low. 
Majority of the patients presented to hospital very late, after the stroke onset. There is therefore the need 
for increased awareness on childhood stroke in our community, in order to facilitate early hospital 
presentation and prompt management to improve the outcome. 
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RÉSUMÉ
Objectif: AVC (Accident Vasculaire Cérébral) se produit généralement plus souvent chez les enfants 
soupçoonés, avec ses conséquences potentielles en découlent, c'est une cause et vertu reconnues  
d'invalidité neurologique dévastatrice et potentiellement mortelle complication très grave d'anémie 
falciforme (AF). Les enfants atteints de drépanocytetosse hémoglobinopathie ont une durée de vie risquée 
accrue de développer un accident vasculaire cérébral. Cette étude vise à évaluer le modelé de présentation 
de l'AVC chez les enfants de SCA à Sokoto, au nord-sud et du Nigeria.
Méthodes: Un examen de tous les dossiers cliniques des enfants atteints de SCA qui ont été d'agnosiques 
et gères pour drépanocytose AVC liés à Sokoto Hôpital Universitaire d'Enseignement d' Usman 
Danfodiyo, Nigeria sur une période de dix-ans (mai 2004 – Avril, 2004) a été entrepris. L'analyse des 
données a été faite en utilisant le logiciel de statistiques pour les sciences sociales (LSSS) la version 20.
Résultats: 15 cas d'AVC de pédiatrie ont été identifiés, sur un total de 416 enfants inscrits avec 5 CA, 
donnant un taux de prévalence de la course de 3.6%, ration hommes: femmes était de 1:1. Tous Les Cas 
d'AVC étaient de l'électrophorèse de l'hémoglobine SS; avec un âge moyen an moment du diagnostic de 
SCA de 2.2 ( 1.5) ans et l'âge moyen an début de l'AVC de 6.3 ( 2.8) ans. Moment de la présentation de 
l'hôpital après le début de le course était de 10 ( 2.5) jours. Hémiparésies et l'aphasie expressives sont les 
Caractéristiques prédominantes. Basé sur les résultants de la neuro-imagerie, la majorité des types 
d'AVCétaient infinitive 71.4%. Aucune mortalité n'a été enregistrée.
Conclusion: La Prévalence de la faucille connexes aux cellules course d'enfance de 3.6% dans cette série 
est relativement faible. Majorité des patients se sont présentes à l'hôpital très tard, aprèsle début de la 
course. Il est donc nécessaire d'avoir la sensibilisation accrue sur les AVC de l'entracte dans notre 
communauté, afin de faciliter la presentation début de l'hôpital et prise enchante rapide pour améliorer les 
résultants.
Mots Clés: Course de pédiatrie, la drépanocytose résultanteprésentation tardive, résultants.
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INTRODUCTION
Stroke generally occurs in children 
more often than previously suspected, with 
its attendant potential consequences (1, 2) 
including persistent hemiparesis, dysphasia, 
seizures or cognitive disturbances, 
depending on the brain vasculature involved. 
It is often an under recognized cause of 
neurologic disability in children, with varied 
 
causes and treatment approaches (3). The 
st
current definition (21  century) explains 
stroke as a sudden neurologic disturbance 
caused by a focal (and not global) cerebral, 
spinal cord or retinal infarction attributable to 
ischaemic or non-traumatic haemorrhage 
within the brain or the ventricular system in a 
defined vascular distribution, based on 
clinical, pathologic or imaging findings with 
symptoms lasting ≥ 24 hours or leading to 
 death, with exclusion of other causes (4).
Mechanisms and risk factors for 
stroke differ between children and adults (5, 
6). Major predisposing factors for childhood 
stroke includes haemoglobinopathies, heart 
diseases, haematologic/clotting disorders, 
cerebral arteriopathies, cerebral sino-venous 
thrombosis and Central Nervous System 
(CNS) infections (3). Children with sickle 
cell haemoglobinopathies have increased 
risk for stroke (7-9) and up to 12% of them 
may develop stroke by 21 years (10).  
Nigerian children with SCA have particularly 
been shown to have higher transcranial 
Doppler (TCD) abnormal velocities 
compared to African-American children 
(11), hence higher risks of developing a 
stroke. 
Hospital based prevalence of sickle 
cell anaemia in the study area was reported to 
be between 4.8 to 11.3% with a carrier rate of 
23.3% (12,13). Acute neurologic symptoms 
may manifest either spontaneously or 
following an acute illness (14). The 
prevalence of stroke among Nigerian sickle 
cell patients was reported to be 12.4 per 1000 
for both children and adults, and 7.4 per 1000 
for children (15). Unlike other SCA related 
complications that commonly follow 
microvascular occlusions, stroke is mainly 
associated with large vessel vasculopathy 
(16). 
Early restoration of blood flow before 
tissue death occurs is the basis for prompt 
intervention required in stroke management. 
However, despite continuous improvement 
in the management of many complications of 
SCA, neurologic complications remain a 
 
significant problem (8). There is paucity of 
information on childhood stroke, particularly 
among SCA patients in our environment. 
Therefore, this study aims to determine the 
pattern of stroke among children with SCA in 
Sokoto and to the best of our knowledge it is 
the first of its kind from this area.
METHODOLOGY       
Involves a review of all the clinical 
records of all SCA children (aged 0 to 15 
years) diagnosed with stroke and managed in 
the Department of Paediatrics, Usmanu 
Danfodiyo University Teaching Hospital, 
Sokoto, over a ten-year period (May, 2004- 
April 2014) was undertaken. Manual sorting 
of the files was done to extract relevant 
information like age, gender, number of 
blood transfusion, age at presentation with 
stroke, mean packed cell volume (PCV), 
computed tomography (CT) scan reports, 
treatment  and outcome. Data analysis was 
done using the statistical package for social 
sciences (SPSS) version 20. Ethical approval 
was given by the UDUTH Ethics Committee. 
RESULTS
Fifteen cases of Paediatrics stroke 
were identified, out of a total of 416 
registered children with SCD, giving a stroke 
prevalence of 3.6%. All the stroke cases were 
of haemoglobin SS electrophoresis. Male to 
Female ratio was 1:1 and mean age at 
diagnosis of SCA of 2.2 (±1.5) years (range 
of 7months to 8 years). The mean age of 
stroke occurrence was 6.3 (±2.8) years with 
those aged 4 to 6 years constituting 60% of 
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the cases. Age specific prevalence of stroke 
were 1.6% (2/125) for Under-five SCA 
patients and 6.3% (13/208) for those aged 
five to 10 years. None of the cases developed 
the stroke from 10 years of age or beyond. 
Table 1 summarizes some relevant clinical 
parameters of the children with SCA stroke.
Mean time of hospital presentation after 
occurrence of the stroke was 10 (±2.5) days 
(range 8hrs to 28days). This was estimated 
from the time onset of the initial presenting 
symptoms of stroke. The mean pre-morbid 
steady state PCV was 21.5 (±2.5) %, with up 
to 60% of the patients having received two or 
more blood transfusions (range of 1-4 times) 
prior to the stroke onset. Two (13.3%) 
patients had a secondary (repeat) stroke 
among the reviewed cases.
Common presenting features 
identified include hemiparesis (100%), 
expressive/motor aphasia (20%), cranial 
nerve palsies (13.3%) and seizures (6.7%). 
None of the patients presented with coma. 
Brain imaging was done in only 7 (46.7%) 
cases. Based on the neuroimaging findings, 
the stroke types identified were due to 
cerebral infarction in 71.4% and 14.3% were 
due to intracerebral haemorrhage. No case of 
subarachnoid haemorrhage was found. 
Diffuse cerebral atrophy was demonstrated 
in 14.3% of the cases, as shown in Table 2.
Treatments given at presentation ranged from 
exchange blood transfusion (33.3%), 
initiation of hyper transfusion program 
(73.3%) to use of hydroxyurea therapy (40%) 
at 15-30mg per kg, depending on the timing 
of Hospital presentation and overall clinical 
condition of the patients. Patients with repeat 
stroke were commenced on hydroxyurea 
treatment as secondary stroke prevention. 
None of the patients had antiplatelets therapy 
but all patients had physiotherapy.
Up to 26.7% still have some residual 
motor deficits (mainly hemiparesis) with 
persistent afebrile seizures in one patient 
(6.7%). There was no mortality recorded but 
26.7% of the patients were lost to follow-up 
as at the time of this write up.
DISCUSSION
This study showed the prevalence of 
sickle cell anaemia related stroke to be 3.6%. 
This figure is lower than that of a similar 
recent report of 5.2% among children with 
SCA in Abuja (17). The lower rate in our 
study may perhaps be explained by genetic 
and environmental differences between the 
study groups as well as the likelihood of more 
hospital presentation after the stroke onset 
among the Abuja cohort. Late hospital 
presentation after the stroke onset was 
alarmingly noted in our study cohort with 
majority presenting after the first week of 
stroke occurrence. In more than half of the 
cases, the delay was attributable to time spent 
on unorthodox care. 
The mean age of stroke occurrence 
found in this study cohort agrees with earlier 
reported age of below 10years by some 
previous studies (17, 18). Low steady state 
PCV was demonstrated in most of the stroke 
patients in this study. This conforms to the 
finding that low haemoglobin is a risk factor 
for SCA related stroke (10). Therefore, 
intensive blood transfusion regimen has been 
demonstrated to reduce the chances of 
developing a stroke by optimizing 
haemoglobin level and suppressing the 
haemoglobin-S level to <30% (10, 19, 20).
Although none of our subjects had 
transcranial Doppler (TCD) studies to predict 
the risk of developing a stroke, elevated 
cerebral blood-flow velocity (using TCD 
studies) in SCD patients may be related to 
severe anemia and cerebral vasodilatation 
caused by cerebral tissue hypoxia. Thus, 
blood transfusion reduces cerebral blood 
flow velocities by reversing these 
abnormalities; with subsequent protection 
against repeat strokes (21-23). Nigerian 
children with haemoglobin SS disease have 
been reported to have higher abnormal TCD 
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velocities compared to African-American 
children (11), hence higher risks of 
developing a stroke. Hankins et al. (24) have 
also reported 10% of sickle cell children 
screened by the TCD to have abnormal 
velocities in the United States. 
Elevated white blood cell count is 
also reported to be another risk factor for 
stroke in SCA (10). However, the steady state 
leukocyte levels were not analyzed in this 
study due to lack of adequate record on such 
parameters during steady state periods. This 
underscores the importance of adequate and 
appropriate patient investigation as well as 
proper documentation of relevant records 
during the follow up periods. Despite the 
availability of neuroimaging techniques in 
our center, which at least helps to confirm and 
to determine the stroke subtypes, less than 
fifty percent of the stroke patients in this 
cohort were able to do this important 
diagnostic test, partly due to poverty. 
No case fatality was recorded in this 
study, which may be attributable to the fact 
that; those patients that would have died early 
after the stroke may not have reached the 
Hospital, as the earliest timing of hospital 
presentation following stroke was 8 hours. 
However, documented stroke case fatality 
rates among SCD children varied, with male 
sex, black race and repeat stroke (s) 
increasing the chances of death (3).
About one quarter of the patients in 
this study had residual motor deficits 
(hemiparesis). This is lower than some earlier 
reports where more than half of the surviving 
children were reported to have long-term 
neurological sequelae, most commonly 
hemiparesis or hemiplegia (3, 25). However, 
the very limited number of subjects in our 
study will hinder a conclusive deduction to be 
made. Therefore, long term follow-up of 
identified cases of stroke is essential; 
especially during the first year following a 
stroke (25). 
Primary stroke prevention in SCA 
patients is most important because even a 
single stroke can lead to irreversible brain 
injury. Transcranial Doppler is a simple, 
inexpensive and noninvasive means of 
monitoring cerebral blood flow changes and 
may aid in making therapeutic decisions 
regarding transfusion for stroke prevention in 
children with SCA (26). Thus, the current 
guidelines in the United Kingdom 
recommend annual TCD screening of 
children with SCA from 3years, though some 
studies have reported a peak incidence of 
sickle cell stroke starting from 2 to 5 years 
(18). Also, hydroxyurea therapy has been 
indicated to significantly decrease elevated 
TCD flow velocities with ultimate benefit in 
stroke prevention in children with SCA (27). 
CONCLUSION
The prevalence of sickle cell related 
childhood stroke of 3.6% in this series is 
relatively low.  Majority of the patients 
presented to hospital very late after the stroke 
onset. There is therefore the need for 
increased awareness on childhood stroke in 
our community, in order to facilitate early 
hospital presentation and prompt effective 
management to improve the outcome. 
RECOMMENDATION
Sickle cell anaemia is a common 
problem in Nigeria, though completely 
preventable through public health education, 
pre-marital counselling and screening of 
prospective couples. Primary prevention of 
stroke in SCA is most important because even 
a single stroke episode can lead to 
irreversible brain damage. The use of TCD 
screening of patients should be made widely 
available, to aid early identification of at risk 
children. 
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Table 1: Details of the clinical parameters of the children with sickle cell stroke 
S/No  Gender   Current age 
(year) 
Age at diagnosis 
of SCA (year) 
Age at time of 
stroke (year) 
Mean steady 
state PCV (%) 
 
1.  F  6 3 6 17 
2.  M  6 1.3 4 25  
3.  F  6 3 6 20  
4.  F  7.5 0.92 5 22  
5.  M  8 8 8 25  
6.  M  8 0.58 7 20  
7.  F  9* 0.58 5 20  
8.  M  12 1.3 8.5 21  
9.  F  12 0.75 9 18  
10.  M  13 1 9 23  


























SCA= sickle cell anaemia; Hb= haemoglobin; PCV= packed cell volume; *repeat stroke 
 







Table 2: Neuroimaging findings of the 7 patients that had the test 
     Cases  Gender  Age at stroke (yr)  Brain imaging findings 
       1  M 6 Left cerebral infarction 
 2  F 7 Right cerebral infarction 
 3  M 9 Left cerebral infarction 










Diffuse cerebral atrophy 
Right intracerebral haemorrhage  
Right cerebral infarction 
 
 
Res. J. of Health Sci. Vol 3(2), April/June 2015                                                       120
